Axovia Therapeutics Revenue and Competitors
Employee Data
- Axovia Therapeutics has 8 Employees.
- Axovia Therapeutics grew their employee count by 60% last year.
Axovia Therapeutics's People
| Name | Title | Email/Phone |
|---|
Axovia Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 86 | 4% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 680 | 30% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5095 | 12% | N/A | N/A |
What Is Axovia Therapeutics?
Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers.\n\nAxovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions.
keywords:N/A
N/A
Total Funding
8
Number of Employees
N/A
Revenue (est)
60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.2M | 8 | -11% | $500M |
#2 | $1.3M | 8 | -11% | N/A |
#3 | $1.6M | 8 | -43% | N/A |
#4 | $1.4M | 8 | -20% | N/A |
#5 | $0.1M | 8 | 0% | N/A |